In 2018, a second “don’t eat me” signal was identified, namely the leukocyte immunoglobulin-like receptors subfamily B (LILRBs), which recognize MHC class I molecules on tumor cells and induce resistance to anti-CD47 mAb therapy [151]. The gene discussed is CD47; the disease is neoplasm.